Actio Biosciences is a startup. 1 investor tracked.
Actio Biosciences is a company founded in 2020 headquartered in the United States. Its most recent tracked round is Series B. Brouky records 2 investors associated with the company.
Actio Biosciences leverages advances in genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare and common diseases. The company applies deep expertise in Mendelian genetics, drug discovery, and data science to pinpoint targets that cause severe rare diseases and also hold promise in more prevalent indications.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.